Followers | 283 |
Posts | 1162 |
Boards Moderated | 0 |
Alias Born | 10/04/2020 |
Wednesday, April 21, 2021 5:00:15 PM
...and THAT's based ALONE on this being a highly likely Buy-Out Candidate already in partnership with a Big Pharma: Oncology Pharma
ALSO like I said previously, IGNORE the present artificial Market Conditions on the OTC based on what the Hedge Funds-MMs are doing behind the scenes. It's totally irrelevant and also it's NOT sustainable long term which I already described in detail.
Fact is they won't be able to prevent this from a sky rocketing run into the Dollar+ Range when the time comes, and that can happen in a single trading session.
But nevertheless this should be rising daily, and IMO by now we should already be trading easily North of $1.00 based alone on their partnership with Oncology Pharma (presently trading at $37.90/Share) with a 15-Year Patent licensing, sub-licensing arrangements to other Big Pharmas via Oncology Pharma, and quarterly royalties about to fall to RGB's their bottom line moving forward!
Like I've said more than once already;a NO BRAINER!!!
What more do you WANT???? Do any of you know of any other Bio-Pharma that fits this description on the OTC?? If so, who?? If this was on NASDAQ that would make sense by far, and it's just a matter of time before than happens.
Hope everyone's loaded to the hilt at this current deep discount price range, if not your going to kick yourself later.
This is NOT A PUMP- it's a plain & simple NO BRAINER based on witnessing first hand scores of prior rising stars like this one being brought to market after filing their IND to engage clinical trials.
Now here's something all of you should be aware of and likely are NOT, but I will educate you...only 5 in 5,000 New Patents for Drug development via filing an IND make it to the pre-clinical testing phase on human subjects. Then subsequently, of those 5, only 1 makes it past pre-clinical then onward to all phase completion preparing for treatment application which is the case with RGBP! FACT! If this was NOT the case they would NOT have been looked at twice by ANY BIG PHARMA!!!
So moving forward let us ALL deal in FACTS!!!...but the vast majority of investors are ignorant of these facts which is no fault of theirs, most just simply don't care to know and that's fine.
If you feel this is a PUMP then by all means DON'T BUY A SINGLE SHARE of RGBP and stand on the side lines as a classic "Lookie-Loo" about to get mowed down by this Bullet Train in the making! But then again, you can always take a position when it hits 0.75.
Don't like it?....Don't buy it!...Move on! Find a better play on NASDAQ or NYSE would be your best bet if you're willing to pay $25-$150/Share. Better yet consider Oncology Pharma currently trading at $38.42 at close of Market today, and that's likely a good idea... I AM!!
If you're among those who do like it and you consider yourself well informed in your decision making, then you may want to consider loading at these levels based on what you can afford, keeping in mind that this is nevertheless a speculative play, but much of the risk has been factored out based on what is factual about RGBP and their Big Pharma PARTNER!!
ONWARD & UPWARD!!
Be well and prosper...
ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM
Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM